Abilify and Azathioprine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Azathioprine (azathioprine sodium). Common drug interactions include contrast media allergy among females and concussion among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Azathioprine. It is created by eHealthMe based on reports of 96 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Azathioprine?

Azathioprine has active ingredients of azathioprine sodium. It is often used in crohn's disease. eHealthMe is studying from 60,623 Azathioprine users. Check the latest studies of Azathioprine.



On Jul, 12, 2026

96 people who take Abilify and Azathioprine together, and have interactions are studied.

Abilify and Azathioprine drug interactions.

What are the common drug interactions of Abilify and Azathioprine, by gender? *:

female:

  1. Contrast media allergy (reaction associated with the use of intravenous contrast material during radiology)
  2. Corona virus infection (infection caused by a corona virus)
  3. Cough
  4. Cyclic vomiting syndrome (prolonged episodes of severe nausea, vomiting)
  5. Lupus-like syndrome (a disease symptom matches with lupus an immune disease)
  6. Nausea (feeling of having an urge to vomit)
  7. Impetigo (contagious skin infection)
  8. Staphylococcal skin infection (skin infection by an infection with staphylococcus bacteria)
  9. Gait disturbance
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

  1. Concussion (short loss of normal brain function in response to a head injury)
  2. Drug level below therapeutic
  3. Diabetes mellitus non-insulin-dependent
  4. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  5. Diarrhoea infectious (bacteria, viruses, and other germs can cause diarrhoea)
  6. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  7. Furuncle (infection of the hair follicle)
  8. Haematochezia (passage of stools containing blood)
  9. Infusion related reaction
  10. Maternal exposure during pregnancy (use of substance during pregnancy)

What are the common drug interactions of Abilify and Azathioprine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Infection
  2. White blood cell count decreased
  3. Small intestinal obstruction (blockage in small intestine)
  4. Varicella
  5. Hyperaesthesia
  6. Infusion related reaction

20-29:

  1. Lupus-like syndrome (a disease symptom matches with lupus an immune disease)
  2. Nausea (feeling of having an urge to vomit)
  3. Impetigo (contagious skin infection)
  4. Staphylococcal skin infection (skin infection by an infection with staphylococcus bacteria)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Oculogyric crisis (a spasmodic movement of the eyeballs into a fixed position due to medicine reaction)
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Rash erythematous (redness of the skin)
  9. Schizoaffective disorder (a mental disorder characterized by disordered thought)
  10. Staphylococcus test positive

30-39:

  1. Fatigue (feeling of tiredness)
  2. Concussion (short loss of normal brain function in response to a head injury)
  3. Drug level below therapeutic
  4. Psychotic disorder due to a general medical condition
  5. Sports injury
  6. Abdominal pain lower
  7. Anxiety
  8. Arthralgia (joint pain)
  9. Back pain
  10. Blood pressure increased

40-49:

  1. Bile duct cancer
  2. Colitis (inflammation of colon)
  3. Cyclic vomiting syndrome (prolonged episodes of severe nausea, vomiting)
  4. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  5. Diarrhoea infectious (bacteria, viruses, and other germs can cause diarrhoea)
  6. Drug ineffective
  7. Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
  8. Eye pain
  9. Fluid retention (an abnormal accumulation of fluid in the blood)
  10. Gingival pain (gum pain)

50-59:

  1. Headache (pain in head)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Paraesthesia oral (sensation of tingling, tickling, prickling, pricking, or burning of a person's oral with no apparent long-term physical effect)
  4. Pruritus (severe itching of the skin)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Asthenia (weakness)
  7. Gait disturbance
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  9. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
  10. Urge incontinence (urinary incontinence)

60+:

  1. Drug ineffective
  2. Feeling jittery
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Disability
  5. Dizziness
  6. Erythema (redness of the skin)
  7. Fall
  8. Fatigue (feeling of tiredness)
  9. Gait disturbance
  10. Infusion related reaction

What are the existing conditions these people have? *

  1. Stress And Anxiety: 14 people, 14.58%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 10 people, 10.42%
  3. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 10.42%
  4. High Blood Cholesterol: 8 people, 8.33%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 7.29%
  6. Inflammatory Bowel Disease: 7 people, 7.29%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 7.29%
  8. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 6 people, 6.25%
  9. Insomnia (sleeplessness): 5 people, 5.21%
  10. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 5 people, 5.21%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Azathioprine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Abilify and Azathioprine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Azathioprine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azathioprine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole and azathioprine sodium (the active ingredients of Abilify and Azathioprine, respectively), and Abilify and Azathioprine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: